Dr. David Lang, MD

NPI: 1396709747
Total Payments
$224,213
2024 Payments
$50,785
Companies
17
Transactions
217
Medicare Patients
119
Medicare Billing
$11,265

Payment Breakdown by Category

Other$139,256 (62.1%)
Consulting$52,324 (23.3%)
Travel$19,211 (8.6%)
Food & Beverage$7,212 (3.2%)
Research$6,081 (2.7%)
Education$129.45 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $136,553 36 60.9%
Consulting Fee $52,324 17 23.3%
Travel and Lodging $19,211 67 8.6%
Food and Beverage $7,212 92 3.2%
Unspecified $6,081 2 2.7%
Honoraria $2,703 1 1.2%
Education $129.45 2 0.1%

Payments by Type

General
$218,132
215 transactions
Research
$6,081
2 transactions

Top Paying Companies

Company Total Records Latest Year
GENZYME CORPORATION $95,545 77 $0 (2024)
Genentech USA, Inc. $51,533 42 $0 (2023)
Novartis Pharmaceuticals Corporation $31,169 26 $0 (2024)
AstraZeneca Pharmaceuticals LP $23,681 36 $0 (2024)
Regeneron Healthcare Solutions, Inc. $17,678 21 $0 (2024)
Blueprint Medicines Corporation $3,187 4 $0 (2023)
F. Hoffmann-La Roche AG $659.38 1 $0 (2024)
Shire North American Group Inc $120.36 1 $0 (2017)
Phadia US Inc. $117.32 1 $0 (2019)
Optinose US, Inc. $115.63 1 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2024 $50,785 36 Novartis Pharmaceuticals Corporation ($25,758)
2023 $58,600 71 GENZYME CORPORATION ($41,128)
2022 $33,170 29 GENZYME CORPORATION ($18,867)
2021 $35,458 34 GENZYME CORPORATION ($20,875)
2020 $76.12 1 ALK-Abello, Inc ($76.12)
2019 $347.51 3 AstraZeneca Pharmaceuticals LP ($230.19)
2018 $24,034 20 Genentech USA, Inc. ($17,043)
2017 $21,744 23 Genentech USA, Inc. ($21,530)

All Payment Transactions

217 individual payment records from CMS Open Payments — Page 1 of 9

Date Company Product Nature Form Amount Type
12/13/2024 Novartis Pharmaceuticals Corporation Consulting Fee Cash or cash equivalent $4,550.00 General
12/13/2024 Novartis Pharmaceuticals Corporation Travel and Lodging In-kind items and services $262.20 General
12/13/2024 Novartis Pharmaceuticals Corporation Travel and Lodging Cash or cash equivalent $239.86 General
12/13/2024 Novartis Pharmaceuticals Corporation Food and Beverage In-kind items and services $171.46 General
12/13/2024 Novartis Pharmaceuticals Corporation Food and Beverage In-kind items and services $75.00 General
12/13/2024 Novartis Pharmaceuticals Corporation Travel and Lodging In-kind items and services $45.00 General
12/13/2024 Novartis Pharmaceuticals Corporation Travel and Lodging In-kind items and services $11.00 General
11/13/2024 GENZYME CORPORATION DUPIXENT (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $5,942.00 General
Category: Immunology
11/13/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $100.10 General
Category: Immunology
11/13/2024 GENZYME CORPORATION DUPIXENT (Biological) Travel and Lodging Cash or cash equivalent $91.12 General
Category: Immunology
11/13/2024 GENZYME CORPORATION DUPIXENT (Biological) Travel and Lodging Cash or cash equivalent $3.50 General
Category: Immunology
10/25/2024 Novartis Pharmaceuticals Corporation Food and Beverage In-kind items and services $55.53 General
09/30/2024 F. Hoffmann-La Roche AG Xolair (Biological) In-kind items and services $659.38 Research
Study: Improving The Quality Of Care For Patients With CSU: Study Design And Patient Baseline Characteristics • Category: Immunology
08/22/2024 Novartis Pharmaceuticals Corporation Consulting Fee Cash or cash equivalent $1,350.00 General
08/12/2024 Novartis Pharmaceuticals Corporation Cash or cash equivalent $5,421.25 Research
Study: Research Publication/ Writing Support
07/17/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $24.36 General
Category: Immunology
07/13/2024 Novartis Pharmaceuticals Corporation Consulting Fee Cash or cash equivalent $4,881.25 General
07/13/2024 Novartis Pharmaceuticals Corporation Travel and Lodging In-kind items and services $197.22 General
07/13/2024 Novartis Pharmaceuticals Corporation Food and Beverage In-kind items and services $130.68 General
07/13/2024 Novartis Pharmaceuticals Corporation Food and Beverage In-kind items and services $118.09 General
07/13/2024 Novartis Pharmaceuticals Corporation Travel and Lodging In-kind items and services $79.40 General
07/13/2024 Novartis Pharmaceuticals Corporation Travel and Lodging Cash or cash equivalent $30.82 General
07/12/2024 Novartis Pharmaceuticals Corporation Travel and Lodging In-kind items and services $399.38 General
05/21/2024 Regeneron Healthcare Solutions, Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $7,340.00 General
05/21/2024 Regeneron Healthcare Solutions, Inc. Travel and Lodging In-kind items and services $554.97 General

Research Studies & Clinical Trials

Study Name Company Amount Records
Research Publication/ Writing Support Novartis Pharmaceuticals Corporation $5,421 1
Improving The Quality Of Care For Patients With CSU: Study Design And Patient Baseline Characteristics F. Hoffmann-La Roche AG $659.38 1

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 3 70 84 $39,587 $6,173
2022 2 23 35 $16,382 $2,615
2021 1 13 19 $6,997 $1,357
2020 1 13 20 $7,160 $1,120
Total Patients
119
Total Services
158
Medicare Billing
$11,265
Procedure Codes
7

All Medicare Procedures & Services

7 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 26 38 $15,862 $2,648 16.7%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 26 26 $18,324 $2,562 14.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 18 20 $5,401 $963.11 17.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 12 24 $9,056 $1,754 19.4%
99221 Initial hospital inpatient care per day, typically 30 minutes Facility 2022 11 11 $7,326 $860.47 11.7%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 13 19 $6,997 $1,357 19.4%
99214 Established patient office or other outpatient, visit typically 25 minutes Facility 2020 13 20 $7,160 $1,120 15.6%

About Dr. David Lang, MD

Dr. David Lang, MD is a Allergy & Immunology healthcare provider based in Cleveland, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1396709747.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Lang, MD has received a total of $224,213 in payments from pharmaceutical and medical device companies, with $50,785 received in 2024. These payments were reported across 217 transactions from 17 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($136,553).

As a Medicare-enrolled provider, Lang has provided services to 119 Medicare beneficiaries, totaling 158 services with total Medicare billing of $11,265. Data is available for 4 years (2020–2023), covering 7 distinct procedure/service records.

Practice Information

  • Specialty Allergy & Immunology
  • Location Cleveland, OH
  • Active Since 04/13/2006
  • Last Updated 03/13/2008
  • Taxonomy Code 207K00000X
  • Entity Type Individual
  • NPI Number 1396709747

Products in Payments

  • DUPIXENT (Biological) $24,465
  • Xolair (Biological) $17,518
  • FASENRA (Drug) $7,047
  • FASENRA (Biological) $6,589
  • AYVAKIT (Drug) $3,187
  • AIRSUPRA (Drug) $2,864
  • TEZSPIRE (Biological) $296.61
  • CINRYZE (Drug) $120.36
  • ImmunoCAP (Device) $117.32
  • Xhance (Drug) $115.63
  • Orladeyo (Drug) $81.82
  • NUCALA (Biological) $76.96
  • Odactra (Drug) $76.12
  • NIOX VERO DEVICE (Device) $58.05
  • EUCRISA (Drug) $34.95
  • GENERAL - BRONCHIAL THERMOPLASTY (Device) $16.55

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Allergy & Immunology Doctors in Cleveland